Two Sigma Advisers LP lessened its stake in Bruker Co. (NASDAQ:BRKR) by 33.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 278,849 shares of the medical research company’s stock after selling 142,700 shares during the period. Two Sigma Advisers LP’s holdings in Bruker were worth $9,570,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company boosted its position in shares of Bruker by 7.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 5,003 shares of the medical research company’s stock valued at $144,000 after purchasing an additional 331 shares in the last quarter. Crossmark Global Holdings Inc. bought a new stake in shares of Bruker during the 3rd quarter valued at about $259,000. Sei Investments Co. boosted its position in shares of Bruker by 23.7% during the 3rd quarter. Sei Investments Co. now owns 101,488 shares of the medical research company’s stock valued at $3,019,000 after purchasing an additional 19,419 shares in the last quarter. TD Asset Management Inc. boosted its position in shares of Bruker by 7.8% during the 3rd quarter. TD Asset Management Inc. now owns 488,268 shares of the medical research company’s stock valued at $14,526,000 after purchasing an additional 35,500 shares in the last quarter. Finally, ETRADE Capital Management LLC boosted its position in shares of Bruker by 10.1% during the 3rd quarter. ETRADE Capital Management LLC now owns 29,484 shares of the medical research company’s stock valued at $877,000 after purchasing an additional 2,701 shares in the last quarter. Hedge funds and other institutional investors own 65.28% of the company’s stock.
Bruker Co. (NASDAQ:BRKR) opened at $29.12 on Monday. Bruker Co. has a 52 week low of $21.83 and a 52 week high of $36.53. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.66 and a current ratio of 2.59. The firm has a market capitalization of $4,542.91, a P/E ratio of 59.43, a P/E/G ratio of 1.93 and a beta of 1.16.
The company also recently declared a quarterly dividend, which was paid on Friday, March 23rd. Investors of record on Tuesday, March 6th were paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.55%. The ex-dividend date of this dividend was Monday, March 5th. Bruker’s dividend payout ratio (DPR) is currently 32.65%.
Several equities research analysts recently commented on the company. Zacks Investment Research lowered Bruker from a “buy” rating to a “hold” rating in a research report on Tuesday, January 9th. BTIG Research assumed coverage on Bruker in a research report on Friday, January 5th. They set a “buy” rating and a $42.00 target price on the stock. Evercore ISI assumed coverage on Bruker in a research report on Wednesday, January 3rd. They set an “in-line” rating and a $36.00 target price on the stock. BidaskClub lowered Bruker from a “strong-buy” rating to a “buy” rating in a research report on Thursday, January 11th. Finally, Cowen restated a “hold” rating and set a $35.00 target price on shares of Bruker in a research report on Thursday, December 21st. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and three have assigned a buy rating to the company’s stock. Bruker has a consensus rating of “Hold” and a consensus target price of $32.62.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3302152/two-sigma-advisers-lp-has-9-57-million-holdings-in-bruker-co-brkr.html.
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR).
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.